IBERE PHARMACEUTICALS's ticker is IBERWS and the CUSIP is G46843119. A total of 42 filers reported holding IBERE PHARMACEUTICALS in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KNOTT DAVID M | 18,000 | $207,000 | 0.07% |
| Radcliffe Capital Management, L.P. | 150,000 | $1,451,000 | 0.04% |
| MARSHALL WACE, LLP | 224,997 | $2,176,000 | 0.01% |
| SPRING CREEK CAPITAL LLC | 200,000 | $152,000 | 0.01% |
| MANGROVE PARTNERS IM, LLC | 75,342 | $57,000 | 0.01% |
| Vestcor Inc | 200,000 | $152,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 12,699 | $123,000 | 0.00% |
| PICTON MAHONEY ASSET MANAGEMENT | 100,000 | $76,000 | 0.00% |
| MOORE CAPITAL MANAGEMENT, LP | 150,000 | $114,000 | 0.00% |
| LINDEN ADVISORS LP | 224,999 | $169,000 | 0.00% |